Information about COVID-19 vaccination and extremely rare blood clots
The Joint Committee on Vaccination and Immunisation has advised that it is preferable for adults aged 18-29 years without underlying health conditions that put them at higher risk of severe disease, to be offered an alternative COVID-19 vaccine to AstraZeneca, if available.
More information is available in the attached leaflet.
Over 50 years of age, or an adult with underlying medical conditions?
All older adults (including health and social care workers over 50 years of age), care home residents, health and social care workers* and adults with certain medical conditions were prioritised in the first phase of the programme because they were at high risk of the complications of COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) and the Joint Committee on Vaccination and Immunisation (JCVI) advises that you should still receive any of the available COVID-19 vaccines. The benefits of vaccination in protecting you against the serious consequences of COVID-19 outweigh any risk of this rare condition. You should also complete your course with the same vaccine you had for the first dose.
If your first dose was with AZ vaccine without suffering any serious side effects you should have the second dose on time as you may still be at high risk of the complications of COVID-19. Having the second dose will give you higher and longer lasting protection.
If you are a healthy person over 40 to 50 years of age without underlying medical conditions?
The MHRA and the JCVI advises that all adults in this age group (including health and social care workers) should still receive any of the available COVID-19 vaccines. The benefits of vaccination in protecting you against the serious consequences of COVID-19 outweigh any risk of this rare condition. You should also complete your course with the same vaccine you had for the first dose.
If you are a healthy younger person aged 18 to 39
The MHRA and the JCVI continue to monitor the benefits and safety of the AZ vaccine in younger people. You should carefully consider the risk to both you and your family and friends of COVID-19 before making a decision.
Currently JCVI has advised that it is preferable for people under 40 who do not have other underlying health conditions to have a vaccine other than AZ. If you choose to have another COVID-19 vaccine you may have to wait to be protected. You may wish to go ahead with the AstraZeneca vaccination after you have considered all the risks and benefits for you.
What about the second dose?
If you have already had a first dose of AZ vaccine without suffering any serious side effects you should complete the course. This includes people aged 18 to 39 years who are health and social care workers, unpaid carers and family members of those who are immunosuppressed. It is expected that the first dose of the vaccine will have given you some protection, particularly against severe disease.
More information is available in the attached leaflet.
Further information is also available from Public Health Wales.